Thomas P. Kelly
2020
In 2020, Thomas P. Kelly earned a total compensation of $2.7M as EVP, Chief Financial Officer & Treasurer at Deciphera Pharmaceuticals, a 27% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $272,278 |
|---|---|
| Option Awards | $1,546,335 |
| Salary | $447,200 |
| Stock Awards | $386,285 |
| Other | $7,386 |
| Total | $2,659,484 |
Kelly received $1.5M in option awards, accounting for 58% of the total pay in 2020.
Kelly also received $272.3K in non-equity incentive plan, $447.2K in salary, $386.3K in stock awards and $7.4K in other compensation.
Rankings
In 2020, Thomas P. Kelly's compensation ranked 4,316th out of 13,090 executives tracked by ExecPay. In other words, Kelly earned more than 67.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,316 out of 13,090 | 67th |
Division Manufacturing | 1,748 out of 5,620 | 69th |
Major group Chemicals And Allied Products | 682 out of 2,253 | 70th |
Industry group Drugs | 583 out of 1,953 | 70th |
Industry Pharmaceutical Preparations | 443 out of 1,458 | 70th |
Source: SEC filing on April 26, 2022.
Kelly's colleagues
We found four more compensation records of executives who worked with Thomas P. Kelly at Deciphera Pharmaceuticals in 2020.